SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Functional characterization of the colorectal cancer metastasis microbiome

The METABAC project aims to investigate the functional roles of bacteria in colorectal cancer metastasis using innovative platforms to uncover their impact on cancer progression and potential therapeutic targets.

Subsidie
€ 1.499.894
2024

Projectdetails

Introduction

Host cells and microbial inhabitants form an intricate ecosystem in the human body, extensively influencing host phenotypes in health and disease. Despite much progress in sequencing-based cancer microbiome research, elucidating functional roles of bacteria in metastasis formation remains an important unsolved challenge. In the METABAC project, we will explore such bacterial roles as drivers of colorectal cancer metastasis. We will investigate new concepts on whether bacteria can equip cancer cells with malignant features, migrate within the host, and potentially represent targets for cancer therapy.

Aim 1: Characterization of Microbial Inhabitants

In Aim 1, my group will characterize the microbial inhabitants of colon tumors and metastases. We will uncover bacterial species and their genetic features in metastases by using:

  • Sequencing-based approaches
  • Imaging-based approaches
  • Culturing-based approaches

Aim 2: Mechanistic Dissection of Bacterial Impacts

In Aim 2, we will mechanistically dissect functional impacts of metastasis-derived bacteria on distinct stages of the metastatic process. For this, we will use specialized platforms that we have pioneered, including:

  1. Organoid platforms
  2. Organ chip platforms
  3. Orthotopic organoid-bacteria co-engraftment platforms

Aim 3: Bacterial Migration and Tropism

In Aim 3, uncovering the tropism, timing, and routes of bacterial migration to different metastasis sites takes center stage. Bacterial strains and organoids derived from different metastasis sites will be co-engrafted into mice and traced to:

  • Lymph node metastases
  • Liver metastases
  • Lung metastases

Conclusion

The METABAC project will provide an unprecedented characterization of microbial roles in metastasis. Our combination of metastasis-derived bacterial strains with novel organoid, organ chip, and in vivo platforms puts us in a unique position to close the gap between cancer microbiome sequencing and mechanistic studies and promises groundbreaking functional insights into host-microbe interactions in cancer and beyond.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.499.894
Totale projectbegroting€ 1.499.894

Tijdlijn

Startdatum1-10-2024
Einddatum30-9-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERGpenvoerder

Land(en)

Germany

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Functional cartography of intestinal host-microbiome interactions

The project aims to elucidate gut microbiome-host interactions through advanced spatial profiling, predicting disease onset and identifying biomarkers for IBD and CRC.

ERC Synergy ...€ 10.382.670
2024
Details

Systematic Triangulation of Pathobiont-Host-Interactions

The project aims to identify disease-driving pathobionts linked to genetic risk factors in IBD and CRC using high-throughput technology and machine learning to enhance precision medicine.

ERC Starting...€ 1.993.688
2024
Details

Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling

This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.

ERC Starting...€ 1.499.323
2024
Details

Microbiome-based diagnostics and therapeutics

This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.

ERC Proof of...€ 150.000
2023
Details

Transcriptional REGUlation as a mediator of bacterial interactions in the microBIOME

REGUBIOME aims to elucidate transcriptional regulation in gut bacteria responses to environmental stimuli, enhancing understanding of their impact on host health and identifying targets for microbiota modulation.

ERC Starting...€ 1.496.479
2023
Details
ERC Synergy ...

Functional cartography of intestinal host-microbiome interactions

The project aims to elucidate gut microbiome-host interactions through advanced spatial profiling, predicting disease onset and identifying biomarkers for IBD and CRC.

ERC Synergy Grant
€ 10.382.670
2024
Details
ERC Starting...

Systematic Triangulation of Pathobiont-Host-Interactions

The project aims to identify disease-driving pathobionts linked to genetic risk factors in IBD and CRC using high-throughput technology and machine learning to enhance precision medicine.

ERC Starting Grant
€ 1.993.688
2024
Details
ERC Starting...

Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling

This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.

ERC Starting Grant
€ 1.499.323
2024
Details
ERC Proof of...

Microbiome-based diagnostics and therapeutics

This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.

ERC Proof of Concept
€ 150.000
2023
Details
ERC Starting...

Transcriptional REGUlation as a mediator of bacterial interactions in the microBIOME

REGUBIOME aims to elucidate transcriptional regulation in gut bacteria responses to environmental stimuli, enhancing understanding of their impact on host health and identifying targets for microbiota modulation.

ERC Starting Grant
€ 1.496.479
2023
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Mapping the mycobiome

Dit project ontwikkelt en valideert een innovatieve detectiemethode voor het mycobiome in de darm, met als doel de rol ervan in gezondheid en ziekte te begrijpen en therapeutische strategieën te verbeteren.

Mkb-innovati...€ 155.400
2015
Details
Mkb-innovati...

Mapping the mycobiome

Dit project ontwikkelt en valideert een innovatieve detectiemethode voor het mycobiome in de darm, met als doel de rol ervan in gezondheid en ziekte te begrijpen en therapeutische strategieën te verbeteren.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 155.400
2015
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.